As a result, more than one million active cases have been successfully treated, while the incidence of the disease – which has cost Indonesia’s economy millions of dollars in lost productivity – has been driven down.
La courbe d’incidence de la maladie est nettement à la baisse ; ce qui épargnera à l’économie de l’Indonésie des millions de dollars en pertes de productivité.